An in vivo platform to select and evolve aggregation-resistant proteins
Protein aggregation remains a significant challenge for manufacturing of protein biopharmaceuticals. Here, the authors demonstrate the use of directed evolution and an assay for in vivo innate protein aggregation-propensity to generate aggregation-resistant scFv fragments.
Guardado en:
Autores principales: | Jessica S. Ebo, Janet C. Saunders, Paul W. A. Devine, Alice M. Gordon, Amy S. Warwick, Bob Schiffrin, Stacey E. Chin, Elizabeth England, James D. Button, Christopher Lloyd, Nicholas J. Bond, Alison E. Ashcroft, Sheena E. Radford, David C. Lowe, David J. Brockwell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7cd4d27ccee2435a841e247a296e334c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lateral opening in the intact β-barrel assembly machinery captured by cryo-EM
por: Matthew G. Iadanza, et al.
Publicado: (2016) -
Inter-domain dynamics in the chaperone SurA and multi-site binding to its outer membrane protein clients
por: Antonio N. Calabrese, et al.
Publicado: (2020) -
Distortion of the bilayer and dynamics of the BAM complex in lipid nanodiscs
por: Matthew G. Iadanza, et al.
Publicado: (2020) -
A force-activated trip switch triggers rapid dissociation of a colicin from its immunity protein.
por: Oliver E Farrance, et al.
Publicado: (2013) -
The role of membrane destabilisation and protein dynamics in BAM catalysed OMP folding
por: Paul White, et al.
Publicado: (2021)